Photochemical Internalization of Bleomycin for Glioma Treatment

Overview

Journal J Biomed Opt

Specialties Biomedical Engineering
Ophthalmology

Date 2012 May 23

PMID 22612148

Citations 23

Authors

Marlon S Mathews

Joseph W Blickenstaff

En-Chung Shih

Genesis Zamora

Van Vo

Chung-Ho Sun

Henry Hirschberg

Steen J Madsen

Affiliations

Soon will be listed here.

Abstract

We study the use of photochemical internalization (PCI) for enhancing chemotherapeutic response to malignant glioma cells in vitro. Two models are studied: monolayers consisting of F98 rat glioma cells and human glioma spheroids established from biopsy-derived glioma cells. In both cases, the cytotoxicity of aluminum phthalocyanine disulfonate (AlPcS2a)-based PCI of bleomycin was compared to AlPcS(2a)-photodynamic therapy (PDT) and chemotherapy alone. Monolayers and spheroids were incubated with AlPcS(2a) (PDT effect), bleomycin (chemotherapy effect), or AlPcS(2a)+bleomycin (PCI effect) and were illuminated (670 nm). Toxicity was evaluated using colony formation assays or spheroid growth kinetics. F98 cells in monolayer/spheroids were not particularly sensitive to the effects of low radiant exposure (1.5 J/cm(2) @ 5 mW/cm(2)) AlPcS(2a)-PDT. Bleomycin was moderately toxic to F98 cells in monolayer at relatively low concentrations-incubation of F98 cells in 0.1 μg/ml for 4 h resulted in 80% survival, but less toxic in human glioma spheroids respectively. In both in vitro systems investigated, a significant PCI effect is seen. PCI using 1.5 J/cm(2) together with 0.25 μg/ml bleomycin resulted in approximately 20% and 18% survival of F98 rat glioma cells and human glioma spheroids, respectively. These results show that AlPcS(2a)-mediated PCI can be used to enhance the efficacy of chemotherapeutic agents such as bleomycin in malignant gliomas.

Citing Articles

Enhancing the Efficacy of Radiation Therapy by Photochemical Internalization of Fibrin-Hydrogel-Delivered Bleomycin.

Laurel S, Gupta K, Nguyen J, Chandekar A, Le J, Berg K Cancers (Basel). 2024; 16(23).

PMID: 39682215 PMC: 11640518. DOI: 10.3390/cancers16234029.

Characterization of the Intracellular Acidity Regulation of Brain Tumor Cells and Consequences for Therapeutic Optimization of Temozolomide.

Tafech A, Jacquet P, Beaujean C, Fertin A, Usson Y, Stephanou A Biology (Basel). 2023; 12(9).

PMID: 37759620 PMC: 10525637. DOI: 10.3390/biology12091221.

Photochemical Internalization with Fimaporfin: Enhanced Bleomycin Treatment for Head and Neck Cancer.

Enzian P, Rahmanzadeh R Pharmaceutics. 2023; 15(8).

PMID: 37631254 PMC: 10458762. DOI: 10.3390/pharmaceutics15082040.

Combinations of Photodynamic Therapy with Other Minimally Invasive Therapeutic Technologies against Cancer and Microbial Infections.

Songca S Int J Mol Sci. 2023; 24(13).

PMID: 37446050 PMC: 10341934. DOI: 10.3390/ijms241310875.

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma.

Yan X, Wang N, Dong J, Wang F, Zhang J, Hu X Front Mol Biosci. 2022; 9:966843.

PMID: 36060266 PMC: 9428515. DOI: 10.3389/fmolb.2022.966843.

References

Zaniboni A, Prabhu S, Audisio R . Chemotherapy and anaesthetic drugs: too little is known. Lancet Oncol. 2005; 6(3):176-81. DOI: 10.1016/S1470-2045(05)01768-7. View

Selbo P, Weyergang A, Hogset A, Norum O, Berstad M, Vikdal M . Photochemical internalization provides time- and space-controlled endolysosomal escape of therapeutic molecules. J Control Release. 2010; 148(1):2-12. DOI: 10.1016/j.jconrel.2010.06.008. View

Pron G, Mahrour N, Orlowski S, Tounekti O, Poddevin B, BELEHRADEK Jr J . Internalisation of the bleomycin molecules responsible for bleomycin toxicity: a receptor-mediated endocytosis mechanism. Biochem Pharmacol. 1999; 57(1):45-56. DOI: 10.1016/s0006-2952(98)00282-2. View

Morantz R, Kimler B, Vats T, Henderson S . Bleomycin and brain tumors. A review. J Neurooncol. 1983; 1(3):249-55. DOI: 10.1007/BF00165609. View

Wallner K, Galicich J, Krol G, Arbit E, Malkin M . Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys. 1989; 16(6):1405-9. DOI: 10.1016/0360-3016(89)90941-3. View

Santini M, Rainaldi G, Indovina P . Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol. 2000; 36(2-3):75-87. DOI: 10.1016/s1040-8428(00)00078-0. View

Eljamel M, Goodman C, Moseley H . ALA and Photofrin fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial. Lasers Med Sci. 2007; 23(4):361-7. DOI: 10.1007/s10103-007-0494-2. View

Selbo P, Sivam G, Fodstad O, Sandvig K, Berg K . In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer. 2001; 92(5):761-6. DOI: 10.1002/1097-0215(20010601)92:5<761::aid-ijc1238>3.0.co;2-4. View

Hirschberg H, Zhang M, Gach H, Uzal F, Peng Q, Sun C . Targeted delivery of bleomycin to the brain using photo-chemical internalization of Clostridium perfringens epsilon prototoxin. J Neurooncol. 2009; 95(3):317-329. PMC: 2773371. DOI: 10.1007/s11060-009-9930-4. View

10.

Ivascu A, Kubbies M . Rapid generation of single-tumor spheroids for high-throughput cell function and toxicity analysis. J Biomol Screen. 2006; 11(8):922-32. DOI: 10.1177/1087057106292763. View

11.

Norum O, Giercksky K, Berg K . Photochemical internalization as an adjunct to marginal surgery in a human sarcoma model. Photochem Photobiol Sci. 2009; 8(6):758-62. DOI: 10.1039/b821129a. View

12.

Stummer W, Reulen H, Meinel T, Pichlmeier U, Schumacher W, Tonn J . Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008; 62(3):564-76. DOI: 10.1227/01.neu.0000317304.31579.17. View

13.

Linnert M, Gehl J . Bleomycin treatment of brain tumors: an evaluation. Anticancer Drugs. 2009; 20(3):157-64. DOI: 10.1097/CAD.0b013e328325465e. View

14.

Nichols M, Foster T . Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. Phys Med Biol. 1994; 39(12):2161-81. DOI: 10.1088/0031-9155/39/12/003. View

15.

Olive P, Durand R . Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev. 1994; 13(2):121-38. DOI: 10.1007/BF00689632. View

16.

Johannesen T, Watne K, Lote K, Norum J, Hennig R, Tvera K . Intracavity fractionated balloon brachytherapy in glioblastoma. Acta Neurochir (Wien). 1999; 141(2):127-33. DOI: 10.1007/s007010050276. View

17.

Poddevin B, Orlowski S, BELEHRADEK Jr J, Mir L . Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol. 1991; 42 Suppl:S67-75. DOI: 10.1016/0006-2952(91)90394-k. View

18.

Drewinko B, Loo T, Brown B, Gottlieb J, Freireich E . Combination chemotherapy in vitro with adriamycin. Observations of additive, antagonistic, and synergistic effects when used in two-drug combinations on cultured human lymphoma cells. Cancer Biochem Biophys. 1976; 1(4):187-95. View

19.

Athanassiou H, Synodinou M, Maragoudakis E, Paraskevaidis M, Verigos C, Misailidou D . Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol. 2005; 23(10):2372-7. DOI: 10.1200/JCO.2005.00.331. View

20.

Madsen S, Kharkhuu K, Hirschberg H . Utility of the F98 rat glioma model for photodynamic therapy. J Environ Pathol Toxicol Oncol. 2007; 26(2):149-55. DOI: 10.1615/jenvironpatholtoxicoloncol.v26.i2.100. View